Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging

Alzheimer’s disease (AD), the most common type of dementia, is a neurodegenerative disorder with a hidden onset, including difficult early detection and diagnosis. Nevertheless, the new crucial biomarkers for the diagnosis and pathogenesis of AD need to be explored further. Here, the common differen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li Min, Geng Rongxin, Li Chen, Meng Fantao, Zhao Hongwei, Liu Jing, Dai Juanjuan, Wang Xuezhen
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2021
Materias:
Acceso en línea:https://doaj.org/article/4b37915e664840cb8a47b0212ab8fdbd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4b37915e664840cb8a47b0212ab8fdbd
record_format dspace
spelling oai:doaj.org-article:4b37915e664840cb8a47b0212ab8fdbd2021-12-05T14:11:05ZDysregulated gene-associated biomarkers for Alzheimer’s disease and aging2081-693610.1515/tnsci-2021-0009https://doaj.org/article/4b37915e664840cb8a47b0212ab8fdbd2021-02-01T00:00:00Zhttps://doi.org/10.1515/tnsci-2021-0009https://doaj.org/toc/2081-6936Alzheimer’s disease (AD), the most common type of dementia, is a neurodegenerative disorder with a hidden onset, including difficult early detection and diagnosis. Nevertheless, the new crucial biomarkers for the diagnosis and pathogenesis of AD need to be explored further. Here, the common differentially expressed genes (DEGs) were identified through a comprehensive analysis of gene expression profiles from the Gene Expression Omnibus (GEO) database. Furthermore, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses revealed that these DEGs were mainly associated with biological processes, cellular components, and molecular functions, which are involved in multiple cellular functions. Next, we found that 9 of the 24 genes showed the same regulatory changes in the blood of patients with AD compared to those in the GEO database, and 2 of the 24 genes showed a significant correlation with Montreal Cognitive Assessment scores. Finally, we determined that mice with AD and elderly mice had the same regulatory changes in the identified DEGs in both the blood and hippocampus. Our study identified several potential core biomarkers of AD and aging, which could contribute to the early detection, differential diagnosis, treatment, and pathological analysis of AD.Li MinGeng RongxinLi ChenMeng FantaoZhao HongweiLiu JingDai JuanjuanWang XuezhenDe Gruyterarticlealzheimer’s diseaseagingdifferentially expressed genesbloodhippocampusNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENTranslational Neuroscience, Vol 12, Iss 1, Pp 83-95 (2021)
institution DOAJ
collection DOAJ
language EN
topic alzheimer’s disease
aging
differentially expressed genes
blood
hippocampus
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle alzheimer’s disease
aging
differentially expressed genes
blood
hippocampus
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Li Min
Geng Rongxin
Li Chen
Meng Fantao
Zhao Hongwei
Liu Jing
Dai Juanjuan
Wang Xuezhen
Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
description Alzheimer’s disease (AD), the most common type of dementia, is a neurodegenerative disorder with a hidden onset, including difficult early detection and diagnosis. Nevertheless, the new crucial biomarkers for the diagnosis and pathogenesis of AD need to be explored further. Here, the common differentially expressed genes (DEGs) were identified through a comprehensive analysis of gene expression profiles from the Gene Expression Omnibus (GEO) database. Furthermore, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses revealed that these DEGs were mainly associated with biological processes, cellular components, and molecular functions, which are involved in multiple cellular functions. Next, we found that 9 of the 24 genes showed the same regulatory changes in the blood of patients with AD compared to those in the GEO database, and 2 of the 24 genes showed a significant correlation with Montreal Cognitive Assessment scores. Finally, we determined that mice with AD and elderly mice had the same regulatory changes in the identified DEGs in both the blood and hippocampus. Our study identified several potential core biomarkers of AD and aging, which could contribute to the early detection, differential diagnosis, treatment, and pathological analysis of AD.
format article
author Li Min
Geng Rongxin
Li Chen
Meng Fantao
Zhao Hongwei
Liu Jing
Dai Juanjuan
Wang Xuezhen
author_facet Li Min
Geng Rongxin
Li Chen
Meng Fantao
Zhao Hongwei
Liu Jing
Dai Juanjuan
Wang Xuezhen
author_sort Li Min
title Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
title_short Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
title_full Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
title_fullStr Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
title_full_unstemmed Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
title_sort dysregulated gene-associated biomarkers for alzheimer’s disease and aging
publisher De Gruyter
publishDate 2021
url https://doaj.org/article/4b37915e664840cb8a47b0212ab8fdbd
work_keys_str_mv AT limin dysregulatedgeneassociatedbiomarkersforalzheimersdiseaseandaging
AT gengrongxin dysregulatedgeneassociatedbiomarkersforalzheimersdiseaseandaging
AT lichen dysregulatedgeneassociatedbiomarkersforalzheimersdiseaseandaging
AT mengfantao dysregulatedgeneassociatedbiomarkersforalzheimersdiseaseandaging
AT zhaohongwei dysregulatedgeneassociatedbiomarkersforalzheimersdiseaseandaging
AT liujing dysregulatedgeneassociatedbiomarkersforalzheimersdiseaseandaging
AT daijuanjuan dysregulatedgeneassociatedbiomarkersforalzheimersdiseaseandaging
AT wangxuezhen dysregulatedgeneassociatedbiomarkersforalzheimersdiseaseandaging
_version_ 1718371418626850816